Metal-on-metal hip replacement devices
are widely acknowledged to have caused serious health problems for hundreds of people in the UK. Medical studies have shown that the failure rate of metal on metal hipreplacements is much greater than alternative types of device.
In March 2012 The Lancet
noted that stemmed metal on metal implants gave poor implant survival compared with other options and should not be implanted.
For many people who had been implanted with metal on metal devices this warning came too late. Thousands of patients in the UK are now bringing compensation claims against the manufacturers of some hip replacement devices for the injuries and health problems they allege are caused by their hip implants.
Biomet hip claims
The specialist medical device
claims team at Leigh Day is currently representing a group of UK patients in a legal claim against Biomet. These patients have been implanted with the Biomet M2a-38 and M2a-Magnum and allege that their implants failed earlier than expected because of an adverse reaction to metal debris.
Adverse reactions to hip debris
Metal debris, which is made up of ions of cobalt and chromium, can cause bone wear and the loosening of the implant, in some patients hip debris can cause excessive tissue damage, and the death of tissue cells.
Many Leigh Day hip clients have reported symptoms including:
- the development of lesions around the hip joint
- discomfort in the buttocks or hip
- swelling and pain in the hip area
- a ‘clicking’ hip
Many people who have been fitted with metal on metal hips
have had to face revision surgery.
Biomet hip devices
The Biomet large head metal-on-metal hip devices were initially marketed as a solution that provided for maximum range of motion, stability and minimal wear in its patients.
The Biomet M2a-38 System is a total hip replacement metal-on-metal device used for primary and revision hip replacement. The U.S FDA first approved the device in July 2001.
The Biomet M2a Magnum System is a total hip replacement metal-on-metal device used for primary and revision hip replacement. The U.S FDA first approved the device in October 2004.
Unlike the M2a-38, it came with a range of large metal-on-metal head components. It also featured a titanium sleeve.
The Biomet claims team
at Leigh Day is now bringing personal injury compensation claims for a group of clients who have suffered early revision surgery, pain, mobility restrictions and other health problems.
If you have been fitted with a Biomet hip replacement and are suffering with health problems you can ask a member of the team for compensation advice. Please contact Jill Paterson
or Thomas Jervis
on 020 7650 1219
for guidance about bringing a faulty medical device claim in the UK, or complete our hip claims enquiry form